Hot topics in the diagnosis and management of skin and soft-tissue infections.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  International Journal of Antimicrobial Agents

• Publication date

  2016-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijantimicag.2016.04.011PMID 27216380
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In vitro Antimicrobial Activity of Chlorquinaldol against Microorganisms Responsible for Skin and Soft Tissue Infections: Comparative Evaluation with Gentamicin and Fusidic Acid

  2017cited by this paper
• Feasibility of an electrostimulation system treatment for wound healing: a case series of patients with chronic ulcers in Barbados

  2016cited by this paper
• Dalbavancin for the treatment of acute bacterial skin and skin structure infections.

  2015cited by this paper
• Hyperbaric oxygen therapy for chronic wounds.

  2015cited by this paper
• Managing skin and soft-tissue infection and nosocomial pneumonia caused by MRSA: a 2014 follow-up survey.

  2015cited by this paper
• Dalbavancin for the treatment of acute bacterial skin and skin structure infections

  2015cited by this paper
• Alternative clinical indications for novel antibiotics licensed for skin and soft tissue infection?

  2015cited by this paper
• Insights and clinical perspectives of daptomycin resistance in Staphylococcus aureus: A review of the available evidence.

  2015cited by this paper
• Risk factors for methicillin-resistant Staphylococcus aureus skin and soft tissue infection in MRSA-colonized patients discharged from a Veterans Affairs hospital

  2015cited by this paper
• Impact of Antimicrobial Stewardship Program (ASP) on Outcomes in Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) in an Acute-Tertiary Care Hospital

  2015cited by this paper
• Vancomycin Combined With Clindamycin for the Treatment of Acute Bacterial Skin and Skin-Structure Infections.

  2015cited by this paper
• Inability of polymerase chain reaction, pyrosequencing, and culture of infected and uninfected site skin biopsy specimens to identify the cause of cellulitis.

  2015cited by this paper
• The antimicrobial activity of prototype modified honeys that generate reactive oxygen species (ROS) hydrogen peroxide

  2015cited by this paper
• Pharmacodynamic Modeling of Bacillary Elimination Rates and Detection of Bacterial Lipid Bodies in Sputum to Predict and Understand Outcomes in Treatment of Pulmonary Tuberculosis

  2015cited by this paper
• Impact of an antimicrobial stewardship program on patients with acute bacterial skin and skin structure infections.

  2014cited by this paper
• Single-dose oritavancin in the treatment of acute bacterial skin infections.

  2014cited by this paper
• Antibiotic treatment patterns across Europe in patients with complicated skin and soft-tissue infections due to meticillin-resistant Staphylococcus aureus: a plea for implementation of early switch and early discharge criteria.

  2014cited by this paper
• Pan-European early switch/early discharge opportunities exist for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections.

  2014cited by this paper
• When antibiotics can be avoided in skin inflammation and bacterial colonization: a review of topical treatments

  2014cited by this paper
• Daptomycin activity tested against 164457 bacterial isolates from hospitalised patients: summary of 8 years of a Worldwide Surveillance Programme (2005-2012).

  2014cited by this paper
• Outcomes from global adult outpatient parenteral antimicrobial therapy programmes: a review of the last decade.

  2014cited by this paper
• Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America.

  2014influential reference
• Engineered honey: In vitro antimicrobial activity of a novel topical wound care treatment.

  2014cited by this paper
• Cryptic resistance in Staphylococcus aureus: a risk for the treatment of skin infection?

  2014cited by this paper
• European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid.

  2014cited by this paper
• Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial.

  2014cited by this paper
• Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis.

  2014cited by this paper
• Oxacillin-susceptible methicillin-resistant Staphylococcusaureus (OS-MRSA), a hidden resistant mechanism among clinically significant isolates in the Wessex region/UK

  2014cited by this paper
• Study to evaluate the role of severity stratification of skin and soft tissue infections (SSTIs) in formulating treatment strategies and predicting poor prognostic factors.

  2014cited by this paper
• Once-weekly dalbavancin versus daily conventional therapy for skin infection.

  2014cited by this paper
• Are Quantitative Bacterial Wound Cultures Useful?

  2014cited by this paper
• Daptomycin: the role of high-dose and combination therapy for Gram-positive infections.

  2013cited by this paper
• Changes in prescriptive practices in skin and soft tissue infections associated with the increased occurrence of community acquired methicillin resistant Staphylococcus aureus.

  2013cited by this paper
• 2012 infectious diseases society of america clinical practice guideline for the diagnosis and treatment of diabetic foot infections.

  2013cited by this paper
• The emerging problem of linezolid-resistant Staphylococcus.

  2013cited by this paper
• Current management of patients hospitalized with complicated skin and soft tissue infections across Europe (2010-2011): assessment of clinical practice patterns and real-life effectiveness of antibiotics from the REACH study.

  2013cited by this paper
• Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based study

  2013cited by this paper
• Linezolid Dependence in Staphylococcus epidermidis Bloodstream Isolates

  2013cited by this paper
• Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: the ESTABLISH-1 randomized trial.

  2013cited by this paper
• Antimicrobial therapy duration: a major matter in the management of severe infections.

  2013cited by this paper
• Identifying patients with cellulitis who are likely to require inpatient admission after a stay in an ED observation unit.

  2013cited by this paper
• Contemporary trends in necrotizing soft-tissue infections in the United States.

  2013cited by this paper
• A Combined Pharmacodynamic Quantitative and Qualitative Model Reveals the Potent Activity of Daptomycin and Delafloxacin against Staphylococcus aureus Biofilms

  2013cited by this paper
• Universal hepatitis B vaccination in Belgium

  2013cited by this paper
• Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement.

  2012cited by this paper
• Does resistance in severe infections caused by methicillin-resistant Staphylococcus aureus give you the ‘creeps’?

  2012cited by this paper
• Considerations of antibiotic therapy duration in community- and hospital-acquired bacterial infections.

  2012cited by this paper
• PCR offers no advantage over culture for microbiologic diagnosis in cellulitis

  2012cited by this paper
• Antibiotic stewardship and early discharge from hospital: impact of a structured approach to antimicrobial management.

  2012cited by this paper
• Factors associated with outcome and duration of therapy in outpatient parenteral antibiotic therapy (OPAT) patients with skin and soft-tissue infections.

  2011cited by this paper
• Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.

  2011cited by this paper
• Diagnosis and management of Skin and Soft-Tissue Infections (SSTI): a Literature Review and Consensus Statement on Behalf of the Italian Society of Infectious Diseases and International Society of Chemotherapy

  2011cited by this paper
• Using antibiotics responsibly: right drug, right time, right dose, right duration.

  2011cited by this paper
• Increasing national burden of hospitalizations for skin and soft tissue infections in children.

  2011cited by this paper
• Decreased antibiotic utilization after implementation of a guideline for inpatient cellulitis and cutaneous abscess.

  2011cited by this paper
• Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets.

  2011cited by this paper
• Assessment of risk factors related to healthcare-associated methicillin-resistant Staphylococcus aureus infection at patient admission to an intensive care unit in Japan

  2011cited by this paper
• Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus.

  2010cited by this paper
• Oxygen in acute and chronic wound healing

  2010cited by this paper
• Baseline factors predicting the duration of intravenous antibiotic therapy for cellulitis in an outpatient setting

  2010cited by this paper
• Surgical Site Infections: Does Inadequate Antibiotic Therapy Affect Patient Outcomes?

  2009cited by this paper
• Treatment options for skin and soft tissue infections caused by meticillin-resistant Staphylococcus aureus:oralvs.parenteral; home vs. hospital.

  2009cited by this paper
• Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective.

  2009cited by this paper
• [Skin and soft tissue infections: classification and epidemiology].

  2009cited by this paper
• Rapid Detection of Staphylococcus aureus and Methicillin-Resistant S. aureus (MRSA) in Wound Specimens and Blood Cultures: Multicenter Preclinical Evaluation of the Cepheid Xpert MRSA/SA Skin and Soft Tissue and Blood Culture Assays

  2009cited by this paper
• [Analysis of current guidelines for the treatment of skin and soft tissue infections].

  2009cited by this paper
• Outpatient Parenteral Antibiotic Therapy in the Elderly: an Italian Observational Multicenter Study

  2009cited by this paper
• Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus.

  2008cited by this paper
• [Skin and soft tissue infections: current therapeutic options].

  2008cited by this paper
• Clinical and Economic Consequences of Failure of Initial Antibiotic Therapy for Hospitalized Patients With Complicated Skin and Skin-Structure Infections

  2008cited by this paper
• National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections.

  2008cited by this paper
• The burden of chronic wounds in the UK.

  2008cited by this paper
• Trends in US Hospital Admissions for Skin and Soft Tissue Infections

  2007cited by this paper
• Decreased Serum Linezolid Levels in a Critically Ill Patient Receiving Concomitant Linezolid and Rifampin

  2007cited by this paper
• Necrotizing soft-tissue infection: diagnosis and management.

  2007cited by this paper
• Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.

  2007cited by this paper
• Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).

  2007cited by this paper
• [Microbiological diagnosis of infections of the skin and soft tissues].

  2007cited by this paper
• Diagnóstico microbiológico de las infecciones de piel y tejidos blandos

  2007cited by this paper
• Methicillin-resistant S. aureus infections among patients in the emergency department.

  2006cited by this paper
• Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus.

  2005cited by this paper
• Primary care Randomised controlled trial of intravenous antibiotic treatment for cellulitis at home compared with hospital

  2004cited by this paper
• Outpatient parenteral antibiotic therapy (OPAT) in different countries: a comparison.

  2004cited by this paper
• Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis.

  2004cited by this paper
• The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: A tool for distinguishing necrotizing fasciitis from other soft tissue infections*

  2004cited by this paper
• Semiquantitative Culture of Open Surgical Wounds for Diagnosis of Surgical Site Infection

  2004cited by this paper
• Practice Guidelines for Outpatient Parenteral Antimicrobial Therapy

  2004cited by this paper
• Managing skin and soft tissue infections: expert panel recommendations on key decision points.

  2003cited by this paper

• Prevalence, microbiology, and antimicrobial susceptibility profile of bacterial skin and soft tissue infections in pediatric patients with malignancies at a referral teaching hospital in Shiraz, Iran

  2025cites this paper
• Preventing Nephrotoxicity of Vancomycin and Attenuating Deep Tissue Infections by Methicillin-Resistant Staphylococcus aureus via Needle-Free Drug Delivery by the Droplette Micromist Technology Device.

  2025cites this paper
• Skin and soft tissue infections

  2025cites this paper
• When infection hurts: golden rules for managing pediatric skin and soft tissue infections

  2025influential citation
• Common cutaneous infections

  2025cites this paper
• Pathogen detection and antibiotic use in granulomatous lobular mastitis: a comparison of mNGS and culture

  2025cites this paper
• Current challenges in acute bacterial skin infection management

  2024cites this paper
• Nanocarrier-Mediated Dermal Drug Delivery System of Antimicrobial Agents for Targeting Skin and Soft Tissue Infections

  2024cites this paper
• Synergistic Antimicrobial Activity of Biogenic Silver Nanoparticles and Acanthospermum australe Essential Oil against Skin Infection Pathogens

  2024cites this paper
• Phage therapy combined with Gum Karaya injectable hydrogels for treatment of methicillin-resistant Staphylococcus aureus deep wound infection in a porcine model.

  2024cites this paper
• In-label, off-label prescription, efficacy and tolerability of dalbavancin: report from a National Registry

  2024cites this paper
• Bacteriophage therapy for Acinetobacter baumannii-induced superficial wounds in experimental mice.

  2023cites this paper
• Epidemiology, aetiology and treatment of skin and soft tissue infections: final report of a prospective multicentre national registry

  2022cites this paper
• Dermatopathology and Skin Cancer

  2022cites this paper
• Current and emerging drug treatment strategies to tackle invasive community-associated methicillin-resistant Staphylococcus aureus (MRSA) infection: what are the challenges?

  2022cites this paper
• Novel N-benzoylimidazolium ionic liquids derived from benzoic and hydroxybenzoic acids as therapeutic alternative against Biofilm-forming bacteria in skin and soft-tissue infections.

  2022cites this paper
• Early Switch From Intravenous to Oral Antibiotics in Skin and Soft Tissue Infections: An Algorithm-Based Prospective Multicenter Pilot Trial

  2022cites this paper
• Bacterial Skin Infections

  2021cites this paper
• Skin and soft tissue infections

  2021cites this paper
• Clonal Lineages, Antimicrobial Resistance, and PVL Carriage of Staphylococcus aureus Associated to Skin and Soft-Tissue Infections from Ambulatory Patients in Portugal

  2021cites this paper
• Transdermal permeation of bacteriophage particles by choline oleate: potential for treatment of soft-tissue infections.

  2020cites this paper
• Challenges and New Therapeutic Approaches in the Management of Chronic Wounds.

  2020cites this paper
• Teicoplanin-loaded chitosan-PEO nanofibers for local antibiotic delivery and wound healing.

  2020cites this paper
• Effectiveness of Dry Hydrogen Peroxide on Reducing Environmental Microbial Bioburden Risk in a Pediatric Oncology Intensive Care Unit.

  2020cites this paper
• Infezioni cutanee

  2020cites this paper
• Focus of infection and microbiological etiology in community-acquired infections in hospitalized adult patients in the Faroe Islands

  2019cites this paper
• What's new in the epidemiology of skin and soft tissue infections in 2018?

  2019cites this paper
• False Alarm: Cutaneous Anthrax Suspicion in a Case of Bullous Erysipelas - The Clinicopathological Consideration

  2019cites this paper
• Infections cutanées

  2019cites this paper
• Guía de práctica clínica para el diagnóstico y manejo de las infecciones de piel y tejidos blandos en Colombia

  2019cites this paper
• Current Epidemiology, Etiology, and Burden of Acute Skin Infections in the United States

  2019cites this paper
• The role of carbapenem-resistant pathogens in cSSTI and how to manage them

  2019cites this paper
• Influence of a visible-light continuous environmental disinfection system on microbial contamination and surgical site infections in an orthopedic operating room.

  2019cites this paper
• The what, when and how in performing and interpreting microbiological diagnostic tests in skin and soft tissue infections

  2018cites this paper
• Overcoming mcr-1 mediated colistin resistance with colistin in combination with other antibiotics

  2018cites this paper
• Recent advances on topical antimicrobials for skin and soft tissue infections and their safety concerns

  2018cites this paper
• Epidemiology and Microbiology of Skin and Soft Tissue Infections: Preliminary Results of a National Registry

  2018cites this paper
• Novel Alkylimidazolium Ionic Liquids as an Antibacterial Alternative to Pathogens of the Skin and Soft Tissue Infections

  2018cites this paper
• Panton-Valentine leukocidin-positive Staphylococcus aureus: a position statement from the International Society of Chemotherapy.

  2018cites this paper
• Environmental effectiveness of pulsed‐xenon light in the operating room

  2018cites this paper
• Infections cutanées

  2018cites this paper
• New insights into classification, epidemiology and microbiology of SSTIs, including diabetic foot infections.

  2018cites this paper
• Hot topics in necrotising skin and soft tissue infections.

  2018cites this paper
• Exiles-Migrants and Reconciliation in the Spanish Low Countries after the Peace of Arras (1579)

  2017cites this paper
• Diagnosis and management of skin and soft-tissue infections (SSTI). A literature review and consensus statement: an update

  2017cites this paper
• The diagnostic conundrum of bacterial infections in cirrhotic patients

  2017cites this paper
• In vitro Antimicrobial Activity of Chlorquinaldol against Microorganisms Responsible for Skin and Soft Tissue Infections: Comparative Evaluation with Gentamicin and Fusidic Acid

  2017cites this paper
• Dalbavancin in the treatment of different gram-positive infections: a real-life experience.

  2017cites this paper
• Granulated sugar for adjuvant treatment of surgical wound infection due to multi-drug-resistant pathogens in a child with sarcoma: a case report and literature review.

  2017cites this paper
• The role of dalbavancin in the multi-disciplinary management of wound infections in orthopaedic surgery

  2017cites this paper
• What is new in the management of skin and soft tissue infections in 2016?

  2017cites this paper
• Mise au point sur l’antibiothérapie des infections bactériennes de la peau et des tissus mous en France

  2017cites this paper
• Activity of dalbavancin tested against Gram-positive clinical isolates causing skin and skin-structure infections in paediatric patients from US hospitals (2014-2015).

  2016cites this paper